Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction

Diagnostic Molecular Pathology

Volumn 6, Issue 6, 1997, Pages 326-332

  Suzuki, Atsushi ^a   Ohta, Shigeru ^a   Shimada, Morimi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Differentiation induction; Gene expression; Malignant rhabdoid tumor; Neuroectodermal; Phenotypic diversity; Polymerase chain reaction; Reverse transcriptase

Indexed keywords

BETA ACTIN; CHROMOGRANIN A; GAMMA INTERFERON; INTERLEUKIN 3; MESSENGER RNA; MYC PROTEIN; MYOD PROTEIN; NEUROFILAMENT PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN S 100; RETINOIC ACID; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROECTODERM; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; TUMOR CELL LINE;

CELL DIFFERENTIATION; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-3; MALE; POLYMERASE CHAIN REACTION; RHABDOID TUMOR; TETRADECANOYLPHORBOL ACETATE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031411956     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199712000-00004     Document Type: Article

References (53)

1. Barger SW, Van-Eldik LJ, Mattson MP. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res 1995;677:167-70.
2. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms' tumor. Results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
3. Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB. The association of embryonal tumors originating in the kidney and in the brain: a report of seven cases. Cancer 1984;54:2137-46.
4. Booz MM, Koelma I, Unnikrishnan M. Case report: primary malignant rhabdoid tumour of the brain. Clin Radial 1996;51:65-6.
5. Brenner CA, Tam AW, Nelson PA, et al. Message amplication phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques 1989;7:1096-103.
6. Brown AL, Chiariotti L, Orlowski CC, et al. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J. Biol Chem 1989;264: 5148-54.
7. Cattoretti G, Schiró R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-38.
8. Cho KR, Rosenshein NB, Epstein JI. Malignant rhabdoid tumor of the uterus. Int J Gynecol Pathol 1989;8:381-7.
9. Cohn RD, Frank Y, Stanek AE, Kalina P. Malignant rhabdoid tumor of the brain and kidney in a child: clinical and pathologic features. Pediatr Neurol 1995;13:65-8.
10. Coker GT, Studelska D, Harmon S, Burke W, O'Malley KL. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res Mole Brain Res 1990;8:93-8.
11. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
12. Egawa S, Uchida T, Koshida K, Kagate Y, Iwabuchi K. Malignant fibrous histiocytoma of the bladder with focal rhabdoid tumor differentiation. J Urol 1994;151:154-6.
13. Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985;5:3610-6.
14. Gansler T, Gerald W, Anderson G, et al. Characterization of a cell line derived from rhabdoid tumor of kidney. Hum Pathol 1991;22: 259-66.
15. Gazin C, de Dinecchin SD, Hampe A, et al. Nucleotide sequence of human c-myc locus: provocative open reading frame within the first exon. EMBO J 1984;3:383-7.
16. Giangaspero F, Zanetti G, Mancini A. Sarcomatous variant of Wilms' tumor: a light and immunohistochemical study of four cases. Tumori 1981;63:367-73.
17. Gonzalez-Crussi F, Goldschmidt RA, Hsueh W, Trujillo YP. Infantile sarcoma with intracytoplasmic filamentous inclusions: distinctive tumor of possible histiocytic origin. Cancer 1982;49: 2365-75.
18. Gururangan S, Bowman LC, Parham DM, et al. Primary extracranial rhabdoid tumors: clinicopathologic features and response to ifosfamide. Cancer 1993;71:2653-9.
19. Haas JE, Palmer NF, Weinberg AG, Beckwith JB. Ultrastructure of malignant rhabdoid tumor of the kidney: a distinctive renal tumor of children. Hum Pathol 1981;12:646-57.
20. Handgretinger R, Kimmig A, Koscielank E, et al. Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor. Cancer Res 1990;50:2177-82.
21. Helman LJ, Ahn TG, Levine MA, et al. Molecular cloning and primary structure of human chromograninA (secretory protein I) cDNA. J Biol Chem 1988;263:11559-63.
22. Horie H, Etoh T, Maie M. Cytogenetic characteristics of a malignant rhabdoid tumor arising from the paravertebral region: a case report. Acta Pathologica Japonica 1992;42:460-5.
23. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver: a distinct clinicopathologic entity. Am J Clin Pathol 1990;94:645-8.
24. Karnes PS, Tran TN, Cui MY, Bogenmann E, Shimada H, Ying KL. Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22) (p15.5;q11.23). Cancer Genet Cytogenet 1991;56:31-8.
25. Kodet R, Newton WA Jr, Sachs N, et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum Pathol 1991;22:674-84.
26. Kumar S, Jakate SM, Marsden BH, Kumar P, Jasani B. Tamm-Horsfall protein is a marker of renal and extra-renal rhabdoid tumours. Int J Cancer 1988;41:386-9.
27. Litman DA, Bhuta S, Barsky SH. Synchronous occurrence of malignant rhabdoid tumor two decades after Wilms' tumor irradiation. Am J Surg Pathol 1993;17:729-37.
28. Martin DM, Carlson RO, Feldman EL. Interferon-gamma inhibits DNA and insulin-like growth factor-II expression in human neuroblastoma cell. J Neurosci Res 1993;34:489-501.
29. Miller JB. Myogenic programs of mouse cell line: expression of myosin heavy chain isoforms, myoD1, and myogenin. J Cell Biol 1990;111:1149-59.
30. Morgan DO, Edman JC, Standring DN, et al. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987;329:301-7.
31. Morii K, Tanaka R, Takahashi Y, Kuwano R. Cloning of cDNAs encoding human S-100 α and ß subunits and differential expression in human tumor cell lines. J Neurosci Res 1992;32:27-33.
32. Muñoz-Fernández MA, Cano E, O'Donnell CA, Doyle J, Liew FY, Fresno M. Tumor necrosis factor-α (TNF-α), interferon-γ, and interleukin-6 but not TNF-ß induce differentiation of neuroblastoma cells: the role of nitric oxide. J Neurochem 1994;62:1330-6.
33. Myers MW, Lazzarini RA, Lee VM-Y. The human mid-sized neurofilament subunits: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J 1987;6:1617-26.
34. Olson TA, Bayar E, Kosnik E, et al. Successful treatment of disseminated central nervous system malignant rhabdoid tumor. J Pediatr Hematol Oncol 1995;17:71-5.
35. Ota S, Crabbe DCG, Tran TN, Triche TJ, Shimada H. Malignant rhabdoid tumor: a study with two established cell lines. Cancer 1993;71:2862-72.
36. Otu AS, Bell RS, Ohashi C, Pollak M, Andrulis IL. Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res 1995;55:129-34.
37. Parham DM, Peiper SC, Robicheaux G. Malignant rhabdoid tumor of the liver: evidence for epithelial differentiation. Arch Pathol Lab Med 1988;112:61-4.
38. Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors: an analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994;18:1010-29.
39. Patel K, Culverwell A, Rossell RJ, Kemshead JT, Phimister E. Vase mini-exon usage by NCAM is not restricted to tumors of neuroectodermal origin. Int J Cancer 1993;54:772-7.
40. Patron M, Palacios J, Rodriguez-Peralto JL, Burgos E, Contreras F. Malignant rhabdoid tumor of the tongue: a case report with immunohistochemical and ultrastructural findings. Oral Surg Oral Med Oral Pathol 1988;65:67-70.
41. Pfeifer-Ohlsson S, Rydnert J, Goustin AS, Larsson E, Betsholtz C, Ohlsson R. Cell-type-specific pattern of myc protooncogen expression in developing human embryos. Proc Natl Acad Sci USA 1985; 82:5050-4.
42. Ramsay G, Evan GI, Bishop JM. The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci USA 1984;81: 7742-6.
43. Schmidt D, Harms D, Zieger G. Malignant rhabdoid tumor of the kidney: histology, ultrastructure, and comment on differential diagnosis. Virchows Arch [A] 1982;398:101-9.
44. Schmidt D, Leuschner I, Harms D, Sprenger E, Schafer HJ. Malignant rhabdoid tumor: a morphological and flow cytometric study. Pathol Res Pract 1989;184:202-6.
45. Small EJ, Gordon GJ, Dahms BB. Malignant rhabdoid tumor of the heart in an infant. Cancer 1985;55:2850-3.
46. Stanton LW, Schwab M, Bishop JM. Nucleotide sequence of human N-myc gene. Proc Natl Acad Sci USA 1986;83:1772-6.
47. Sullivan KA, Castle VP, Hanash SM, Feldman EL. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 1995;147:1790-8.
48. Takaue Y, Kawano Y, Reading CL, et al. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 α on the growth of purified human peripheral blood progenitors. Blood 1990;76:330-5.
49. Tsokos M, Kouraklis G, Chandra RS, Bhagavan BS, Triche TJ. Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype. Arch Pathol Lab Med 1989;113:115-20.
50. Tsujimura T, Wada A, Kawano K, Iwasa A, Mizutani S. A case of malignant rhabdoid tumor arising from soft parts in the prepubic region. Acta Pathol Jpn 1989;39:677-82.
51. Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M. Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study. Hum Pathol 1985;16:1235-42.
52. Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-12.
53. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol 1995;12:233-48.